Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial

Clinical Infectious Diseases · Published 2026-06-17 · DOI 10.1093/cid/ciag349

Free full text

Authors (10)

David Alexanderian, Fabiano Ramos, Soumya Chatterjee, Alexandre Vargas Schwarzbold, Ana Paula Loch, Ariane Cristina Barboza Zanetti, Qiuxu Chen, Jason Martin, Matthew T Onorato, Germán Áñez

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Alexanderian, D., Ramos, F., Chatterjee, S., et al. (2026). Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag349

Related articles